Point of Care INR, ACT, D-Dimer & Rotem/Teg Participants
Lab Level 1 & 2, Thrombophilia, Homocysteine, DOAC, FXIII, FVIII Inhibitor,
ADAMTS-13, Emicizumab, FVIII & FIX Treatment Monitoring Participants
Follow us on online
@UKNEQASBC
We are a UKAS (United Kingdom Accreditation Service) accredited organisation, our accreditation is limited to those activities described on our UKAS schedule of accreditation; also a copy of the ISO 17043:2023 certificate can be found here.
We are a member of the UK NEQAS organisation, and comply with the UK NEQAS Code of Practice
|
|
|
|